Literature DB >> 7889579

Mivacurium-induced neuromuscular blockade during sevoflurane and halothane anaesthesia in children.

R F Kaplan1, M Garcia, R S Hannallah.   

Abstract

The neuromuscular blocking effects of mivacurium during sevoflurane or halothane anaesthesia was studied in 38 paediatric patients aged 1-12 yr. All received premedication with midazolam, 0.5 mg.kg-1 po and an inhalational induction with up to 3 MAC of either agent in 70% N2O and O2. The ulnar nerve was stimulated at the wrist by a train-of-four stimulus every ten seconds and the force of adduction of the thumb recorded with a Myotrace force transducer. Anaesthesia was maintained with a one MAC end-tidal equivalent of either volatile agent for five minutes before patients received mivacurium (0.2 mg.kg-1) iv. The onset of maximal blockade occurred in 2.4 +/- 1.26 (mean +/- SD) min with halothane and 1.8 +/- 0.54 min with sevoflurane (NS). Four patients failed to achieve 100% block (3 halothane, 1 sevoflurane). The times from injection to 5, 75, and 95% recovery during sevoflurane (9.8 +/- 2.6, 19.5 +/- 4.4, and 24.2 +/- 4.8 min) were greater than during halothane anaesthesia (7.2 +/- 2.2, 15.0 +/- 4.0, 19.2 +/- 4.9 min, respectively (P < 0.005). All patients demonstrated complete spontaneous recovery of neuromuscular function (T1 > 95%, T4/T1 > 75%) during the surgery which lasted 24-63 min. All patients showed clinical signs of full recovery of neuromuscular blockade (i.e., headlift, gag, or cough). Pharmacological reversal was not required. It is concluded that following a single intubating dose of mivacurium, the time to maximum relaxation was not different during halothane and sevoflurane anaesthesia; recovery times to 5, 75 and 95% twitch height were longer during sevoflurane anaesthesia and neuromuscular reversal was not necessary.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7889579     DOI: 10.1007/BF03010565

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  16 in total

1.  Duration of halothane anesthesia and neuromuscular blockade with d-tubocurarine.

Authors:  R D Miller; M Crique; E I Eger
Journal:  Anesthesiology       Date:  1976-03       Impact factor: 7.892

2.  Comparative neuromuscular effects of pancuronium, gallamine, and succinylcholine during forane and halothane anesthesia in man.

Authors:  R D Miller; W L Way; W M Dolan; W C Stevens; E I Eger
Journal:  Anesthesiology       Date:  1971-11       Impact factor: 7.892

3.  [A clinical and experimental study on potentiation with sevoflurane of neuromuscular blocking effects of vecuronium and pancuronium].

Authors:  T Itagaki; K Tai; N Katsumata; H Suzuki
Journal:  Masui       Date:  1988-08

4.  Prolonged mivacurium-induced neuromuscular block.

Authors:  D R Bevan
Journal:  Anesth Analg       Date:  1993-07       Impact factor: 5.108

5.  Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency.

Authors:  N G Goudsouzian; A A d'Hollander; J Viby-Mogensen
Journal:  Anesth Analg       Date:  1993-07       Impact factor: 5.108

Review 6.  Plasma cholinesterase: gene and variations.

Authors:  E J Pantuck
Journal:  Anesth Analg       Date:  1993-08       Impact factor: 5.108

7.  Comparison between sevoflurane and halothane for paediatric ambulatory anaesthesia.

Authors:  Y Naito; S Tamai; K Shingu; R Fujimori; K Mori
Journal:  Br J Anaesth       Date:  1991-10       Impact factor: 9.166

8.  Vecuronium-induced neuromuscular blockade during enflurane, isoflurane, and halothane anesthesia in humans.

Authors:  S M Rupp; R D Miller; P J Gencarelli
Journal:  Anesthesiology       Date:  1984-02       Impact factor: 7.892

9.  Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients.

Authors:  D Ostergaard; F S Jensen; E Jensen; L T Skovgaard; J Viby-Mogensen
Journal:  Acta Anaesthesiol Scand       Date:  1992-10       Impact factor: 2.105

10.  Clinical pharmacology of mivacurium chloride (BW B1090U) in children during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia.

Authors:  J B Sarner; B W Brandom; S K Woelfel; M L Dong; M C Horn; D R Cook; B F McNulty; V J Foster
Journal:  Anesth Analg       Date:  1989-02       Impact factor: 5.108

View more
  2 in total

Review 1.  Sevoflurane in paediatric anaesthesia: a review.

Authors:  K L Goa; S Noble; C M Spencer
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

Review 2.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.